Weiss Multi-Strategy Advisers’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-8,987	Closed	-$1.8M	–	629
2023 Q1	$1.8M	Sell	8,987 -2,708	-23%	-$569K	0.04%	436
2022 Q4	$2.78M	Buy	11,695 +3,734	+47%	+$796K	0.08%	331
2022 Q3	$1.59M	Buy	7,961 +5,551	+230%	+$1.06M	0.04%	441
2022 Q2	$351K	Buy	+2,410	New	+$342K	0.01%	575
2016 Q3	–	Sell	-3,645	Closed	-$202K	–	415
2016 Q2	$202K	Sell	3,645 -4,355	-54%	-$274K	0.02%	374
2016 Q1	$502K	Sell	8,000 -1,000	-11%	-$66.5K	0.03%	387
2015 Q4	$847K	Sell	9,000 -126	-1%	-$11.7K	0.07%	258
2015 Q3	$733K	Buy	+9,126	New	+$1.01M	0.06%	288
2015 Q1	–	Sell	-11,000	Closed	-$1.07M	–	435
2014 Q4	$1.07M	Sell	11,000 -3,000	-21%	-$278K	0.05%	279
2014 Q3	$1.09M	Hold	14,000	–	–	0.04%	367
2014 Q2	$884K	Buy	14,000 +570	+4%	+$33.9K	0.03%	435
2014 Q1	$902K	Buy	+13,430	New	+$1.04M	0.03%	509